Search
for
Sort by
Research 181–210 of 1000+
- Minoxidil for Endocrine Therapy–Induced Alopecia in Women With Breast Cancer—Saint Agatha’s Blessing?
- The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
- Efficacy and Safety of Cinobufacin Combined with Chemotherapy for Advanced Breast Cancer: A Systematic Review and Meta‐Analysis
- Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients
- Transcription Regulation and Protein Subcellular Localization of the Truncated Basic Hair Keratin hHb1-ΔN in Human Breast Cancer Cells
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein
- Therapeutic Effect of Superficial Scalp Hypothermia on Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Improving preparation for scalp cooling: Learning from women undergoing chemotherapy for early‐stage breast cancer—The COOL study
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.
- Alopecia areata and myasthenia gravis presenting as paraneoplastic phenomena of breast cancer
- A Quantitative Measurement Method for Nuclear-Pleomorphism Scoring in Breast Cancer
- The Potential of Ultrasound Technology and Chemotherapy Carriers in Breast Cancer Treatment
- Scalp hypothermia for the prevention of chemotherapy-induced alopecia in breast cancer
- Assessment of hair loss and skin changes during treatment in Asian breast cancer patients: A prospective cohort study
- Study of alpha mangostin as a chemoprotective agent for breast cancer via activation of the p53 pathway
- Spiritual well-being and quality of life among newly diagnosed Palestinian women with breast cancer: a prospective study
- Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study
- Patient-reported outcomes of adverse events after perioperative chemotherapy for breast cancer: A prospective observational study
- SAT-724 Persistently Elevated Alkaline Phosphatase in an Older Woman with a History of Breast Cancer
- Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Randomized, Controlled, Pilot Study
- Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review
- B/N-doped carbon nano-onions as nanocarriers for targeted breast cancer therapy
- In vitro anti-proliferative and antioxidant activites of chloroform extract of christia vespertilionis on mcf 7 and mda-mb-231 breast cancer cells
- Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines
- EXERCISE-INDUCED EXTRACELLULAR VESICLES DELAY TUMOR DEVELOPMENT VIA IGNITING THE INFLAMMATION IN THE IMMUNOLOGICALLY COLD BREAST CANCER MODEL
- Ectopic Expression of a Truncated Isoform of Hair Keratin 81 in Breast Cancer Alters Biophysical Characteristics to Promote Metastatic Propensity
- Factors Influencing Using Scalp Cryotherapy to Promote Hair Regrowth in Breast Cancer Patients Receiving Chemotherapy
- Supplementary Material for: Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Supplementary Material for: Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer